Genomic sequencing is crucial to understanding the epidemiology and evolution of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Often, genomic studies rely on remnant diagnostic material, typically nasopharyngeal (NP) swabs, as input into whole-genome SARS-CoV-2 next-generation sequencing pipelines. Saliva has proven to be a safe and stable specimen for the detection of SARS-CoV-2 RNA via traditional diagnostic assays; however, saliva is not commonly used for SARS-CoV-2 sequencing. Using the ARTIC Network amplicon-generation approach with sequencing on the Oxford Nanopore MinION, we demonstrate that sequencing SARS-CoV-2 from saliva produces genomes comparable to those from NP swabs, and that RNA extraction is necessary to generate complete genomes from saliva. In this study, we show that saliva is a useful specimen type for genomic studies of SARS-CoV-2.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Alpert, Tara; Vogels, Chantal B. F.; Breban, Mallery I.; Petrone, Mary E.; Wyllie, Anne L.; Grubaugh, Nathan D.; and Fauver, Joseph R., "Sequencing SARS-CoV-2 Genomes From Saliva" (2022). Journal Articles: Epidemiology. 165.